Authors: FETY R ROLLAND F BARBERIHEYOB M HARDOUIN A CAMPION L CONROY T MERLIN JL RIVIERE A PERROCHEAU G ETIENNE MC MILANO G

Citation: R. Fety et al., CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS, Clinical cancer research, 4(9), 1998, pp. 2039-2045

Authors: DELECROIX V FUMOLEAU P PERROCHEAU G AZLI N FETY R PRIOU F MAUGARD C RIVA A LEMEVEL B

Citation: V. Delecroix et al., ANTHRACYCLINE AS 2ND LINE CHEMOTHERAPY (CT) FOR METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH TAXOTERE (TXT), European journal of cancer, 33, 1997, pp. 666-666

Authors: FUMOLEAU P DELECROIX V GENTIN M PERROCHEAU G LOUBOUTIN C FETY R AZLI N RIVA A

Citation: P. Fumoleau et al., DOCETAXEL (D) IN COMBINATION WITH VINORELBINE (V) AS FIRST LINE CT INPTS WITH MBC - PHASE-I DOSE-FINDING STUDY, European journal of cancer, 31A, 1995, pp. 938-938

Authors: LOUBOUTIN JP MAUGARDLOUBOUTIN C PERROCHEAU G GENTIN M DELECROIX V AZLI N FUMOLEAU P

Citation: Jp. Louboutin et al., AN EVALUATION OF THE NEUROTOXICITY OF A PHASE-I DOSE-FINDING STUDY OFDOCETAXEL (D) IN COMBINATION WITH VINORELBIN (V), European journal of cancer, 31A, 1995, pp. 970-970

Authors: FUMOLEAU P PERROCHEAU G MAUGARDLOUBOUTIN C LEMEVEL B

Citation: P. Fumoleau et al., PACLITAXEL (TAXOL(R)) AND DOCETAXEL (TAXOTERE(R)) AS SINGLE AGENTS - RESULTS OF PHASE-II TRIALS, Bulletin du cancer, 82(8), 1995, pp. 629-636

Authors: CHEVALLIER B PERROCHEAU G

Citation: B. Chevallier et G. Perrocheau, RELATION DOSE INTENSITY IN CHEMOTHERAPY - THE EXAMPLE OF BREAST-CANCER, Bulletin du cancer, 82, 1995, pp. 9-15